Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University College, London
With
National Institutes of Health (NIH)
Rising Tide Foundation
Medical Research Council
Tata Memorial Hospital
Tata Memorial Centre
University of Stellenbosch
King Hussein Cancer Center
University of Malaya
University Ghent
M.D. Anderson Cancer Center
Mount Vernon Cancer Centre at Mount Vernon Hospital
University of Cape Town
National Cancer Institute (NCI)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Consecutive patients with histologically confirmed head and neck cancers of the oropharynx, larynx, hypopharynx and nasopharynx (Stage I-III) that have given consent for radical radiotherapy.
2. Consecutive histologically confirmed primary cervical cancer patients (Stage IB-IIIB including pelvic node positive) that have given consent for radical radiotherapy.
3. Consecutive histologically confirmed primary prostate cancer patients (T1-4N0M0) that have given consent for radical radiotherapy.
4. Mental capacity to understand and consent to participate in the study.
5. Patients aged ≥18years.
You may not be if
1. Patients requiring radiotherapy after curative surgery or surgery that is intended to remove as much of the tumour as possible.
2. Patients receiving palliative radiotherapy
3. Patients aged \< 18years.
Clareo Health | ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
